Biopharma Dealmaking Should Accelerate In 2026, PwC Predicts

 
• By Joseph Haas
  
Forecast
PwC analysts expect an acceleration of biopharma dealmaking in 2026 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business